On this page
The evidence at a glance
The study, in context
A preliminary study associated resting MOTS-c levels with muscle and jump measures in 20 active adults, but not peak oxygen uptake. It did not show that administering MOTS-c increases strength or endurance.
MOTS-c serum concentration and lower-body strength: a preliminary study (2023)
- Study design
- Cross-sectional physiological association study.
- Who or what was studied
- 20 physically active healthy volunteers: 17 men and three women.
- What was measured
- Resting peptide level, jump force and power, muscle mass and peak oxygen uptake.
- What it found
- Levels correlated with several muscle and jump measures but not peak oxygen uptake.
- Important limit
- Small observational sample; cannot establish direction, causality or a treatment response.
Strength and endurance are not interchangeable
A jump test and a maximal oxygen-uptake test describe different aspects of physical capacity. A summary saying that the peptide tracks with fitness loses that distinction. The paper reported associations with certain force, power and muscle measures, while peak oxygen uptake did not show the same relationship. Keeping those outcomes separate makes the finding more informative than a generic performance headline.
Nobody was assigned a peptide treatment
The study measured a circulating level and compared it with physical measurements. It did not establish what would happen if a person received MOTS-c. A higher measured level could relate to other characteristics of the participants. The question of whether changing the level changes an outcome remains different from the question of whether two measurements vary together in this sample.
A small sample is a starting point
Twenty people can provide an exploratory record, but it is a limited basis for defining a normal range or making broad predictions. The distribution of men and women also matters when considering who the findings describe. Ask whether a proposed claim has been reproduced in larger and more varied groups rather than treating a preliminary association as a validated personal assessment tool.
Read the result beside other human observations
The acute exercise study reported a different pattern across its measured fitness outcomes. The blood-versus-muscle aging study concerns another distinction: the compartment being sampled. These papers do not have to be forced into one simple narrative. Their differences can help identify what is uncertain about circulating measurements and why a single blood number cannot automatically select a treatment.
Questions for a performance claim
Ask whether the proposed benefit is strength, power, endurance or recovery and how it was measured in treated humans. Ask whether the product itself has relevant evidence rather than relying on an association with the natural molecule. Then read the provider review for care and purchase details. A clear separation between those records is more useful than turning a small study into a promise of athletic improvement.
Read the source
Research findings and provider statements are different evidence.